使用多对比度MRI输入与深度学习实现超低剂量18F-氟比他班淀粉样蛋白PET成像
本研究回顾性分析39例患者共40组同步淀粉样蛋白(18F-氟比他班)PET/MRI数据,利用低剂量PET(原始列表模式数据的1%)联合多对比度MRI输入通过卷积神经网络合成全剂量样PET图像。PET-plus-MR模型合成的图像在所有质量指标上均较低剂量图像明显改善,淀粉样蛋白状态判读准确率为89%(71/80次判读),与全剂量图像的判读者自身可重复性(91%,73/80)相似。结论认为同步采集的MRI与超低剂量PET数据可用于合成全剂量样淀粉样蛋白PET图像。
要点
- 低剂量PET联合多对比度MRI输入可合成质量接近全剂量的淀粉样蛋白PET图像。
- PET-plus-MR模型合成图像全部评分≥3分,评分>3分的比例与全剂量图像相似(差值-10%,95%CI:-15%,-5%)。
- 合成图像判读淀粉样蛋白状态准确率89%(71/80),与全剂量图像判读者自身可重复性91%(73/80)相近。
核心结论
- 同步采集的MRI与超低剂量PET数据可用于合成全剂量样淀粉样蛋白PET图像。
研究设计与样本
- 回顾性分析2016年3月至2017年10月间39例患者(男16例、女23例;平均年龄±标准差67岁±8)共40组同步18F-氟比他班淀粉样蛋白PET/MRI检查数据。
关键影像表现/征象
- 随机选取原始列表模式PET数据的1%模拟低剂量采集,以低剂量PET联合多幅MR图像(PET-plus-MR模型)或仅低剂量PET(PET-only模型)为输入预测全剂量PET图像。
- 合成图像(尤其是PET-plus-MR模型)在所有质量指标上较低剂量图像明显改善。
- PET-plus-MR模型合成图像与全剂量图像的区域标准摄取值比值(SUVR)差异均值和方差最小。
诊断标准与关键数值
- 两名阅片者采用五分制(5分为优)评估图像质量并判定淀粉样蛋白状态(阳性或阴性)。
- PET-plus-MR图像全部评分≥3分;评分>3分的比例与全剂量图像相似(差值-10%〔80次判读中8次〕,95%CI:-15%,-5%)。
- 淀粉样蛋白状态判读准确率为89%(71/80次判读),全剂量图像判读者自身可重复性为91%(73/80次判读)。
临床应用与阅片要点
- 阅片时可参考PET-plus-MR模型合成的全剂量样图像进行淀粉样蛋白状态判读,其判读准确率与全剂量图像判读者自身可重复性相近。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To reduce radiotracer requirements for amyloid PET/MRI without sacrificing diagnostic quality by using deep learning methods. Materials and Methods Forty data sets from 39 patients (mean age ± standard deviation [SD], 67 years ± 8), including 16 male patients and 23 female patients (mean age, 66 years ± 6 and 68 years ± 9, respectively), who underwent simultaneous amyloid (fluorine 18 [18F]-florbetaben) PET/MRI examinations were acquired from March 2016 through October 2017 and retrospectively analyzed. One hundredth of the raw list-mode PET data were randomly chosen to simulate a low-dose (1%) acquisition. Convolutional neural networks were implemented with low-dose PET and multiple MR images (PET-plus-MR model) or with low-dose PET alone (PET-only) as inputs to predict full-dose PET images. Quality of the synthesized images was evaluated while Bland-Altman plots assessed the agreement of regional standard uptake value ratios (SUVRs) between image types. Two readers scored image quality on a five-point scale (5 = excellent) and determined amyloid status (positive or negative). Statistical analyses were carried out to assess the difference of image quality metrics and reader agreement and to determine confidence intervals (CIs) for reading results. Results The synthesized images (especially from the PET-plus-MR model) showed marked improvement on all quality metrics compared with the low-dose image. All PET-plus-MR images scored 3 or higher, with proportions of images rated greater than 3 similar to those for the full-dose images (-10% difference [eight of 80 readings], 95% CI: -15%, -5%). Accuracy for amyloid status was high (71 of 80 readings [89%]) and similar to intrareader reproducibility of full-dose images (73 of 80 [91%]). The PET-plus-MR model also had the smallest mean and variance for SUVR difference to full-dose images. Conclusion Simultaneously acquired MRI and ultra-low-dose PET data can be used to synthesize full-dose-like amyloid PET images. © RSNA, 2018 Online supplemental material is available for this article. See also the editorial by Catana in this issue.
引用
- Chen KT, Gong E, de Carvalho Macruz FB, et al. Ultra-Low-Dose 18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs. Radiology. 2018. PMID: 30526350. doi:10.1148/radiol.2018180940
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。